Oral tolerance: Boom or bust for autoimmunity

Inflammatory Bowel Diseases

Volumn 2, Issue 3, 1996, Pages 211-213

  Mayer, Lloyd ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27644543944     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780020308     Document Type: Review

References (21)

1. Theofilopoulos AN. Molecular pathology of autoimmunity. Prologue. In: Bona CA, Siminovitch KA, Zanetti M, Theofilopoulos AN, eds. Molecular pathology of autoimmune diseases. Switzerland: Harwood Academic Publishers, 1993:1.
2. Elkon KB. Apoptosis in SLE - too little or too much. Clin Exp Rheumatol 1994;12:553.
3. Green DR, Webb DR. Saying the 'S' word in public. Immunol Today 1993;14:523.
4. Mayer L, Panja A, Li Y. Antigen presentation in the gut: death to the dogma. Immunol Res 1991;10:356.
5. Wells HG. Studies on the chemistry of anaphylaxis II: experiments with isolated proteins, especially those of hen's egg. J Infect Dis 1911;9:147.
6. Challacombe SJ, Tomasi TB. Systemic tolerance and secretory immunity after oral immunization. J Exp Med 1980;152: 1459.
7. Thomas HC, Parrot MV. The induction of tolerance to a soluble protein by oral administration. Immunology 1974;27: 631.
8. Miller SD, Hanson DG. Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin. J Immunol 1979;123:2344.
9. Mattingly JA, Waksman BH. Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed rat Peyer's patches after oral administration. J Immunol 1978;121:1878.
10. Mattingly JA, Eardley DD, Kemp JD, Gershon RK. Induction of suppressor cells in rat spleen: influence of microbial stimulation. J Immunol 1979;122:787.
11. Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbecke GJ. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA 1986;83:7443.
12. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulating of transforming growth factor beta, interleukin 4. J Exp Med 1992;176:1355.
13. Whitacre CC, Gienapp IE, Orosz CG, Bitar DM. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 1991;147:2155.
14. al-Sabbagh A, Miller A, Santos LM, Weiner HL. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur J Immunol 1994;24:2104.
15. Miller A, al-Sabbagh A, Santos LM, Das MP, Weiner HL. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol 1993;151:7307.
16. Okumura S, McIntosh K, Drachman DB. Oral administration of acetylcholine receptor: Effects on experimental myasthenia gravis. Ann Neurol 1994;36:704.
17. + T lymphocytes. J Immunol 1989;142: 748.
18. Weiner HL, Mackin GA, Matsui M, Orav EJ, et al. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993;259:1321.
19. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993;261:1727.
20. Elson CO. Cholera toxin as a mucosal adjuvant: effects of H-2 major histocompatibility complex and lps genes. Infect Immun 1992;60:2874.
21. Husby S, Mestecky J, Moldoveanu Z, Holland S, Elson CO. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol 1994;152:4663.